3 hours Amicus Therapeutics (NASDAQ:FOLD) Upgraded to Buy by StockNews.com MarketBeat
StockNews.com raised Amicus Therapeutics from a “hold” rating to a “buy” rating in a report on Monday.
StockNews.com raised Amicus Therapeutics from a “hold” rating to a “buy” rating in a report on Monday.